No follow up. It doesn't matter though as they will be doing a trial for high risk ARDS patients and not covid related.
If MSB can't do a deal in the short term, It will be a capital raise and hope they find big pockets.
I'm not fussed with another capital raise, if it's to fund future trials and wipe of that dam debt!!!
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-423
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.005(0.34%) |
Mkt cap ! $1.649B | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.49 | $1.44 | $1.069M | 731.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 31996 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 25283 | 6 |
View Market Depth
| Last trade - 10.51am 21/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |